Skip to main content
Log in

Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Background

Transjugular-intrahepatic portosystemic-shunt (TIPS) and SX-Ella stent Danis (DE stent) are available rescue therapies for refractory variceal bleeding in cirrhosis. Any delay in appropriate therapy is associated with high mortality. Determining the best timing for rescue TIPS is crucial and largely unknown.

Methods

Cirrhotic patients with refractory variceal bleed (n = 121) who underwent rescue TIPS within 24-h (n = 66) were included. Their early rebleed (upto 42 days) rate, 6-week and 1-year survival were compared with matched patients who underwent rescue DE stent (n = 55). Outcomes based on timing of TIPS (within 8-h/8-24 h) were also analyzed.

Results

At baseline, patients who received rescue DE stent were sicker with higher MELD score (27.6 ± 8.3 vs. 22.3 ± 7.9; p = 0.001), active bleeding at endoscopy (54.5% vs. 34.8%; p = 0.03) compared to TIPS-group. After propensity score matching, adjusting for MELD-Na score and non-bleed complications, DE patients (n = 34) had higher mortality at 6-week (17/34; 50%) and 1-year (29/34; 85.3%) compared to TIPS-group (20.6% and 38.2%, respectively; both p < 0.02), with higher rebleeding rate (10/34; 29.4% vs. 1/34; 2.9%, p = 0.003). Rescue TIPS placed within 8-h compared with 8–24 h had lower 6-week (48.6% vs. 12.9%; p = 0.003) and 1-year mortality (62.9% vs. 16.1%, p = 0.001) despite comparable rebleed rates (2/31; 6.5% vs. 2/35;5.7%; p = 0.90). Post-TIPS Portal pressure gradient at 6-weeks and 1-year was comparable between survivors and non-survivors. Active bleeding at endoscopy [HR = 11.8; 95% CI 2.96–47.53], presence of AKI [HR = 5.8; 95% CI 1.92–17.41], MELD-Na > 24 [HR = 1.1; 95% CI 1.0–1.17], mean arterial pressure > 64.5 mmHg [HR = 0.8; 95% CI 0.75–0.92] independently predicted 6-week mortality in rescue TIPS-group.

Conclusions

Rescue TIPS placement preferably within 8-h of refractory variceal bleed improves short- and long-term survival. It provides better outcome than DE stent for control of bleeding and prevention of rebleeding, even in patients with high MELD-Na score.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

All data generated or analysed during this study are included in this published article (and its supplementary information files).

Abbreviations

AVB:

Acute variceal bleeding

DE:

SX-Ella stent Danis

TIPS:

Transjugular intrahepatic portosystemic shunt

AKI:

Acute kidney injury

CT:

Computed tomography

MAP:

Mean arterial pressure

HVPG:

Hepatic venous pressure gradient

SEMS:

Self-expandable metallic stent

CTP:

Child–Turcotte–Pugh score

MELD-Na:

Model for End Stage Liver disease sodium score

HE:

Hepatic encephalopathy

PRBC:

Packed red blood cell

PPG:

Portal pressure gradient

References

  1. de Franchis R. Expanding consensus in portal hypertension. J Hepatol. 2015;63(3):743–752

    Article  PubMed  Google Scholar 

  2. Sarin SK, Kumar A, Angus PW, Baijal SS, Baik SK, Bayraktar Y, et al. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int. 2011;5(2):607–624

    Article  PubMed  PubMed Central  Google Scholar 

  3. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22(1):332–354

    PubMed  Google Scholar 

  4. Loffroy R. Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. WJG. 2013;19(37):6131

    Article  PubMed  PubMed Central  Google Scholar 

  5. Garcia-Pagán JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol. 2013;58(1):45–50

    Article  PubMed  Google Scholar 

  6. Lv Y, Yang Z, Liu L, Li K, He C, Wang Z, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4(8):587–598

    Article  PubMed  Google Scholar 

  7. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–335

    Article  PubMed  Google Scholar 

  8. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40(4):793–801

    Article  PubMed  Google Scholar 

  9. Li S, Zhang C, Lin LL, Wang Q, Zuo HX, Zhan AL, et al. Early-TIPS versus current standard therapy for acute variceal bleeding in cirrhosis patients: a systemic review with meta-analysis. Front Pharmacol. 2020;11:603

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nicoară-Farcău O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, et al. Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data. Gastroenterology. 2021;160(1):193-205.e10

    Article  PubMed  Google Scholar 

  11. Trebicka J, Gu W, Ibáñez-Samaniego L, Hernández-Gea V, Pitarch C, Garcia E, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. J Hepatol. 2020;73(5):1082–1091

    Article  PubMed  Google Scholar 

  12. Trebicka J. Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close? J Hepatol. 2017;66(2):442–450

    Article  PubMed  Google Scholar 

  13. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology. 1996;111(1):138–146

    Article  CAS  PubMed  Google Scholar 

  14. Maimone S, Saffioti F, Filomia R, Alibrandi A, Isgrò G, Calvaruso V, et al. Predictors of re-bleeding and mortality among patients with refractory variceal bleeding undergoing salvage transjugular intrahepatic portosystemic shunt (TIPS). Dig Dis Sci. 2019;64(5):1335–1345

    Article  PubMed  Google Scholar 

  15. Azoulay D, Castaing D, Ichai P, Saliba F, Bismuth H. Intrahepatic portosystemic shunt as a salvage treatment of uncontrolled hemorrhage caused by rupture of esophageal varices in patients with liver cirrhosis. Presse Med. 1996;25(18):842–846

    CAS  PubMed  Google Scholar 

  16. Maiwall R, Jamwal KD, Bhardwaj A, Bhadoria AS, Maras JS, Kumar G, et al. SX-Ella stent danis effectively controls refractory variceal bleed in patients with acute-on-chronic liver failure. Dig Dis Sci. 2018;63(2):493–501

    Article  PubMed  Google Scholar 

  17. Makris K, Spanou L. Acute kidney injury: definition, pathophysiology and clinical phenotypes. Clin Biochem Rev. 2016;37(2):85–98

    PubMed  PubMed Central  Google Scholar 

  18. Gaba RC, Lakhoo J. What constitutes liver failure after transjugular intrahepatic portosystemic shunt creation? A proposed definition and grading system. Ann Hepatol. 2016;15(2):230–235

    CAS  PubMed  Google Scholar 

  19. Modha K, Kapoor B, Lopez R, Sands MJ, Carey W. Symptomatic heart failure after transjugular intrahepatic portosystemic shunt placement: incidence, outcomes, and predictors. Cardiovasc Intervent Radiol. 2018;41(4):564–571

    Article  PubMed  Google Scholar 

  20. Rössle M, Grandt D. Early transjugular intrahepatic portosystemic shunt in patients with cirrhosis and variceal bleeding. Hepatology. 2010;52(5):1847–1850

    Article  PubMed  Google Scholar 

  21. Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol. 2002;37(5):703–704

    Article  CAS  PubMed  Google Scholar 

  22. Lopera JE. Role of emergency transjugular intrahepatic portosystemic shunts. Semin intervent Radiol. 2005;22(04):253–265

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mohan BP, Chandan S, Khan SR, Kotagiri R, Kassab LL, Olaiya B, et al. Self-expanding metal stents versus TIPS in treatment of refractory bleeding esophageal varices: a systematic review and meta-analysis. Endosc Int Open. 2020;8(3):E291-300

    Article  PubMed  PubMed Central  Google Scholar 

  24. Emergency transjugular intrahepatic portosystemic shunt: an effective and safe treatment for uncontrolled variceal bleeding | SpringerLink [Internet]. [cited 2022 May 13]. Available from: https://link.springer.com/article/https://doi.org/10.1007/s11605-019-04146-8

  25. Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg. 1993;165(5):566–571

    Article  CAS  PubMed  Google Scholar 

  26. Encarnacion CE, Palmaz JC, Rivera FJ, Alvarez OA, Chintapalli KN, Lutz JD, et al. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol. 1995;6(5):687–694

    Article  CAS  PubMed  Google Scholar 

  27. Maiwall R, Kumar A, Bhadoria AS, Jindal A, Kumar G, Bhardwaj A, et al. Utility of N-acetylcysteine in ischemic hepatitis in cirrhotics with acute variceal bleed: a randomized controlled trial. Hepatol Int. 2020;14(4):577–586

    Article  PubMed  Google Scholar 

  28. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol. 2002;36(4):494–500

    Article  PubMed  Google Scholar 

  29. Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol. 2003;98(5):1167–1174

    Article  PubMed  Google Scholar 

  30. Ahmed R, Santhanam P, Rayyan Y. MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol. 2015;27(10):1226–1227

    Article  PubMed  Google Scholar 

  31. Tzeng WS, Wu RH, Lin CY, Chen JJ, Sheu MJ, Koay LB, et al. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage. Korean J Radiol. 2009;10(5):481–489

    Article  PubMed  PubMed Central  Google Scholar 

  32. Orloff MJ, Bell RH, Hyde PV, Skivolocki WP. Long-term results of emergency portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis. Ann Surg. 1980;192(3):325–340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Russo MW, Jacques PF, Mauro M, Odell P, Brown RS. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. Liver Transpl. 2002;8(3):271–277

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

AM: conceptualization, review and original draft preparation (supporting), analysis (equal), editing of manuscript (equal); SV, AJ: investigation (lead), analysis (equal) and original draft preparation (lead); YP: project administration, original draft preparation (supporting); SKS: conceptualization (lead), review and editing of manuscript (equal).

Corresponding author

Correspondence to Shiv K. Sarin.

Ethics declarations

Conflict of interest

Amar Mukund, Sudhir Vasistha, Ankur Jindal, Yashwant Patidar and Shiv K. Sarin have no conflict of interest to declare.

IRB approval

Obtained (IEC/2022/93/MA17).

Patient consent statement

Need for patient consent waived by IRB.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 13 KB)

Supplementary file2 (TIFF 1103 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mukund, A., Vasistha, S., Jindal, A. et al. Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed. Hepatol Int 17, 954–966 (2023). https://doi.org/10.1007/s12072-022-10479-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-022-10479-5

Keywords

Navigation